Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
This treatment is designed for both the face & body, offering impressive results with minimal discomfort
It is important to note that retatrutide is an investigational compound not approved by the FDA for human use, and all research peptides are sold strictly for laboratory investigationthe clinical retatrutide results referenced in this article come from Eli Lillys regulated trials
The dosage and frequency of administration should be determined by a healthcare professional based on individual research goals
PT-141, measured in a single radioligand displacement series against I-NDP-alpha-MSH on membranes from BHK570 cells stably expressing each human subtype, returned Ki 0.25 nM at MC4R, 6.4 nM at MC1R, 17 nM at MC5R and 53 nM at MC3R, roughly 26-fold, 68-fold and 210-fold preference for MC4R over MC1R, MC5R and MC3R respectively
